These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35200164)

  • 21. Differentiation of pluripotent stem cells into retinal pigmented epithelium.
    Croze RH; Clegg DO
    Dev Ophthalmol; 2014; 53():81-96. PubMed ID: 24732763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular models and therapies for age-related macular degeneration.
    Forest DL; Johnson LV; Clegg DO
    Dis Model Mech; 2015 May; 8(5):421-7. PubMed ID: 26035859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological aspects of RPE cell transplantation.
    Sugita S; Mandai M; Kamao H; Takahashi M
    Prog Retin Eye Res; 2021 Sep; 84():100950. PubMed ID: 33482342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
    Leach LL; Clegg DO
    Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular regeneration strategies for macular degeneration: past, present and future.
    Chichagova V; Hallam D; Collin J; Zerti D; Dorgau B; Felemban M; Lako M; Steel DH
    Eye (Lond); 2018 May; 32(5):946-971. PubMed ID: 29503449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced pluripotent stem cell-based therapy for age-related macular degeneration.
    Bracha P; Moore NA; Ciulla TA
    Expert Opin Biol Ther; 2017 Sep; 17(9):1113-1126. PubMed ID: 28664762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal Pigment Epithelium Replacement Therapy for Age-Related Macular Degeneration: Are We There Yet?
    Sharma R; Bose D; Maminishkis A; Bharti K
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():553-572. PubMed ID: 31914900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem Cell Transplantation Therapy for Retinal Degenerative Diseases.
    Han F; Xu G
    Adv Exp Med Biol; 2020; 1266():127-139. PubMed ID: 33105499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The identification of small molecules that stimulate retinal pigment epithelial cells: potential novel therapeutic options for treating retinopathies.
    Artero-Castro A; Popelka S; Jendelova P; Motlik J; Ardan T; Rodriguez Jimenez FJ; Erceg S
    Expert Opin Drug Discov; 2019 Feb; 14(2):169-177. PubMed ID: 30616395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light Exposure.
    Hallam D; Collin J; Bojic S; Chichagova V; Buskin A; Xu Y; Lafage L; Otten EG; Anyfantis G; Mellough C; Przyborski S; Alharthi S; Korolchuk V; Lotery A; Saretzki G; McKibbin M; Armstrong L; Steel D; Kavanagh D; Lako M
    Stem Cells; 2017 Nov; 35(11):2305-2320. PubMed ID: 28913923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Preclinical Safety Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells for Macular Degeneration.
    Mazzilli JL; Snook JD; Simmons K; Domozhirov AY; Garcia CA; Wetsel RA; Zsigmond EM; Westenskow PD
    J Ocul Pharmacol Ther; 2020; 36(1):65-69. PubMed ID: 31596637
    [No Abstract]   [Full Text] [Related]  

  • 32. Retinal pigment epithelium differentiation of stem cells: current status and challenges.
    Uygun BE; Sharma N; Yarmush M
    Crit Rev Biomed Eng; 2009; 37(4-5):355-75. PubMed ID: 20528731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soy Protein Nanofiber Scaffolds for Uniform Maturation of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
    Phelan MA; Kruczek K; Wilson JH; Brooks MJ; Drinnan CT; Regent F; Gerstenhaber JA; Swaroop A; Lelkes PI; Li T
    Tissue Eng Part C Methods; 2020 Aug; 26(8):433-446. PubMed ID: 32635833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fabricating retinal pigment epithelial cell sheets derived from human induced pluripotent stem cells in an automated closed culture system for regenerative medicine.
    Matsumoto E; Koide N; Hanzawa H; Kiyama M; Ohta M; Kuwabara J; Takeda S; Takahashi M
    PLoS One; 2019; 14(3):e0212369. PubMed ID: 30865653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient and robust induction of retinal pigment epithelium cells by tankyrase inhibition regardless of the differentiation propensity of human induced pluripotent stem cells.
    Ito A; Ye K; Onda M; Morimoto N; Osakada F
    Biochem Biophys Res Commun; 2021 May; 552():66-72. PubMed ID: 33743349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of human embryonic stem cell therapies for age-related macular degeneration.
    Carr AJ; Smart MJ; Ramsden CM; Powner MB; da Cruz L; Coffey PJ
    Trends Neurosci; 2013 Jul; 36(7):385-95. PubMed ID: 23601133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the cAMP and Transforming Growth Factor-β Pathway Increases Proliferation to Promote Re-Epithelialization of Human Stem Cell-Derived Retinal Pigment Epithelium.
    Choudhary P; Gutteridge A; Impey E; Storer RI; Owen RM; Whiting PJ; Bictash M; Benn CL
    Stem Cells Transl Med; 2016 Jul; 5(7):925-37. PubMed ID: 27112176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.
    Ben M'Barek K; Habeler W; Monville C
    Adv Exp Med Biol; 2018; 1074():625-632. PubMed ID: 29721996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental stem cell replacement transplantation in retinal pigment epithelium atrophy.
    Neroeva NV; Neroev VV; Katargina LA; Ryabina MV; Ilyukhin PA; Karmokova AG; Losanova OA; Maybogin AM; Kharitonov AE; Eremeev AV; Lagarkova MA
    Vestn Oftalmol; 2022; 138(3):7-15. PubMed ID: 35801874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pluripotent Stem Cell-Based Therapies in Combination with Substrate for the Treatment of Age-Related Macular Degeneration.
    Pennington BO; Clegg DO
    J Ocul Pharmacol Ther; 2016 Jun; 32(5):261-71. PubMed ID: 26889704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.